Submission Details
| 510(k) Number | K110277 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2011 |
| Decision Date | August 15, 2011 |
| Days to Decision | 196 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K110277 is an FDA 510(k) clearance for the RAPIDPOINT 405 NEONATAL BILIRUBIN, a Bilirubin (total And Unbound) In The Neonate Test System (Class I — General Controls, product code MQM), submitted by Siemens Healthcare Diagnostics (Norowood, US). The FDA issued a Cleared decision on August 15, 2011, 196 days after receiving the submission on January 31, 2011. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1113.
| 510(k) Number | K110277 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 31, 2011 |
| Decision Date | August 15, 2011 |
| Days to Decision | 196 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | MQM — Bilirubin (total And Unbound) In The Neonate Test System |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1113 |